NASDAQ:TPTX - Turning Point Therapeutics Price Target & Analyst Ratings

$52.19
+0.39 (+0.75 %)
(As of 08/25/2019 02:36 PM ET)
Today's Range
$49.28
Now: $52.19
$52.9099
50-Day Range
$37.00
MA: $42.14
$51.30
52-Week Range
$24.21
Now: $52.19
$54.48
Volume112,232 shs
Average Volume112,898 shs
Market Capitalization$1.64 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

Turning Point Therapeutics (NASDAQ:TPTX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
7 Wall Street analysts have issued ratings and price targets for Turning Point Therapeutics in the last 12 months. Their average twelve-month price target is $48.7143, suggesting that the stock has a possible downside of 6.66%. The high price target for TPTX is $58.00 and the low price target for TPTX is $42.00. There are currently 7 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score: 3.003.003.00N/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $48.7143$48.7143$47.1667N/A
Price Target Upside: 6.66% downside24.33% upside57.22% upsideN/A

Turning Point Therapeutics (NASDAQ:TPTX) Consensus Price Target History

Turning Point Therapeutics (NASDAQ:TPTX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/24/2019GuggenheimInitiated CoverageBuy ➝ Buy$58.00MediumView Rating Details
5/13/2019Leerink SwannInitiated CoverageOutperform$42.00HighView Rating Details
5/13/2019Royal Bank of CanadaInitiated CoverageOutperform ➝ Outperform$48.00HighView Rating Details
5/13/2019Svb LeerinkInitiated CoverageOutperform ➝ Outperform$42.00HighView Rating Details
5/13/2019Canaccord GenuityInitiated CoverageBuy$48.00HighView Rating Details
5/13/2019Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$50.00HighView Rating Details
5/13/2019Wells Fargo & CoInitiated CoverageOutperform ➝ Outperform$53.00HighView Rating Details
(Data available from 8/25/2017 forward)
This page was last updated on 8/25/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel